Global Radiation Curable Formulation Market Research Report 2021

1 Radiation Curable Formulation Market Overview

• 1.1 Product Overview and Scope of Radiation Curable Formulation
• 1.2 Radiation Curable Formulation Segment by Type
  • 1.2.1 Global Radiation Curable Formulation Market Size Growth Rate Analysis by Type 2021 VS 2027
  • 1.2.2 Ultraviolet (UV) Curing
  • 1.2.3 Electron beam (EB) Curing
• 1.3 Radiation Curable Formulation Segment by Application
  • 1.3.1 Global Radiation Curable Formulation Consumption Comparison by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Coatings
  • 1.3.3 Inks
  • 1.3.4 Adhesives
  • 1.3.5 Electronics
• 1.4 Global Market Growth Prospects
  • 1.4.1 Global Radiation Curable Formulation Revenue Estimates and Forecasts (2016-2027)
  • 1.4.2 Global Radiation Curable Formulation Production Capacity Estimates and Forecasts (2016-2027)
  • 1.4.3 Global Radiation Curable Formulation Production Estimates and Forecasts (2016-2027)
• 1.5 Global Market Size by Region
  • 1.5.1 Global Radiation Curable Formulation Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
  • 1.5.2 North America Radiation Curable Formulation Estimates and Forecasts (2016-2027)
  • 1.5.3 Europe Radiation Curable Formulation Estimates and Forecasts (2016-2027)
  • 1.5.5 China Radiation Curable Formulation Estimates and Forecasts (2016-2027)
  • 1.5.5 Japan Radiation Curable Formulation Estimates and Forecasts (2016-2027)

2 Market Competition by Manufacturers

• 2.1 Global Radiation Curable Formulation Production Capacity Market Share by Manufacturers (2016-2021)
• 2.2 Global Radiation Curable Formulation Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Radiation Curable Formulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.4 Global Radiation Curable Formulation Average Price by Manufacturers (2016-2021)
• 2.5 Manufacturers Radiation Curable Formulation Production Sites, Area Served, Product Types
• 2.6 Radiation Curable Formulation Market Competitive Situation and Trends
  • 2.6.1 Radiation Curable Formulation Market Concentration Rate
  • 2.6.2 Global 5 and 10 Largest Radiation Curable Formulation Players Market Share by Revenue
  • 2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

• 3.1 Global Production Capacity of Radiation Curable Formulation Market Share by Region (2016-2021)
• 3.2 Global Radiation Curable Formulation Revenue Market Share by Region (2016-2021)
• 3.3 Global Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.4 North America Radiation Curable Formulation Production
  • 3.4.1 North America Radiation Curable Formulation Production Growth Rate (2016-2021)
  • 3.4.2 North America Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.5 Europe Radiation Curable Formulation Production
  • 3.5.1 Europe Radiation Curable Formulation Production Growth Rate (2016-2021)
  • 3.5.2 Europe Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.6 China Radiation Curable Formulation Production
  • 3.6.1 China Radiation Curable Formulation Production Growth Rate (2016-2021)
  • 3.6.2 China Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.7 Japan Radiation Curable Formulation Production
  • 3.7.1 Japan Radiation Curable Formulation Production Growth Rate (2016-2021)
  • 3.7.2 Japan Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Radiation Curable Formulation Consumption by Region

• 4.1 Global Radiation Curable Formulation Consumption by Region
  • 4.1.1 Global Radiation Curable Formulation Consumption by Region
  • 4.1.2 Global Radiation Curable Formulation Consumption Market Share by Region
• 4.2 North America
  • 4.2.1 North America Radiation Curable Formulation Consumption by Country
  • 4.2.2 U.S.
  • 4.2.3 Canada
• 4.3 Europe
  • 4.3.1 Europe Radiation Curable Formulation Consumption by Country
  • 4.3.2 Germany
  • 4.3.3 France
  • 4.3.4 U.K.
  • 4.3.5 Italy
  • 4.3.6 Russia
• 4.4 Asia Pacific
  • 4.4.1 Asia Pacific Radiation Curable Formulation Consumption by Region
  • 4.4.2 China
  • 4.4.3 Japan
  • 4.4.4 South Korea
  • 4.4.5 Taiwan
  • 4.4.6 Southeast Asia
  • 4.4.7 India
  • 4.4.8 Australia
• 4.5 Latin America
  • 4.5.1 Latin America Radiation Curable Formulation Consumption by Country
  • 4.5.2 Mexico
  • 4.5.3 Brazil

5 Production, Revenue, Price Trend by Type

• 5.1 Global Radiation Curable Formulation Production Market Share by Type (2016-2021)
• 5.2 Global Radiation Curable Formulation Revenue Market Share by Type (2016-2021)
• 5.3 Global Radiation Curable Formulation Price by Type (2016-2021)

6 Consumption Analysis by Application

• 6.1 Global Radiation Curable Formulation Consumption Market Share by Application (2016-2021)
• 6.2 Global Radiation Curable Formulation Consumption Growth Rate by Application (2016-2021)

7 Key Companies Profiled

• 7.1 BASF SE
  • 7.1.1 BASF SE Radiation Curable Formulation Corporation Information
  • 7.1.2 BASF SE Radiation Curable Formulation Product Portfolio
  • 7.1.3 BASF SE Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.1.4 BASF SE Main Business and Markets Served
  • 7.1.5 BASF SE Recent Developments/Updates
• 7.2 DIC
  • 7.2.1 DIC Radiation Curable Formulation Corporation Information
  • 7.2.2 DIC Radiation Curable Formulation Product Portfolio
  • 7.2.3 DIC Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.2.4 DIC Main Business and Markets Served
  • 7.2.5 DIC Recent Developments/Updates
• 7.3 Arkema (Sartomer)
  • 7.3.1 Arkema (Sartomer) Radiation Curable Formulation Corporation Information
  • 7.3.2 Arkema (Sartomer) Radiation Curable Formulation Product Portfolio
  • 7.3.3 Arkema (Sartomer) Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.3.4 Arkema (Sartomer) Main Business and Markets Served
  • 7.3.5 Arkema (Sartomer) Recent Developments/Updates
• 7.4 Cytec (Solvay S.A.)
  • 7.4.1 Cytec (Solvay S.A.) Radiation Curable Formulation Corporation Information
  • 7.4.2 Cytec (Solvay S.A.) Radiation Curable Formulation Product Portfolio
  • 7.4.3 Cytec (Solvay S.A.) Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.4.4 Cytec (Solvay S.A.) Main Business and Markets Served
  • 7.4.5 Cytec (Solvay S.A.) Recent Developments/Updates
• 7.5 DuPont
  • 7.5.1 DuPont Radiation Curable Formulation Corporation Information
  • 7.5.2 DuPont Radiation Curable Formulation Product Portfolio
  • 7.5.3 DuPont Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.5.4 DuPont Main Business and Markets Served
  • 7.5.5 DuPont Recent Developments/Updates
• 7.6 Royal DSM
  • 7.6.1 Royal DSM Radiation Curable Formulation Corporation Information
  • 7.6.2 Royal DSM Radiation Curable Formulation Product Portfolio
  • 7.6.3 Royal DSM Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.6.4 Royal DSM Main Business and Markets Served
  • 7.6.5 Royal DSM Recent Developments/Updates
• 7.7 IGM Resins
  • 7.7.1 IGM Resins Radiation Curable Formulation Corporation Information
  • 7.7.2 IGM Resins Radiation Curable Formulation Product Portfolio
  • 7.7.3 IGM Resins Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.7.4 IGM Resins Main Business and Markets Served
  • 7.7.5 IGM Resins Recent Developments/Updates
• 7.8 Allnex
  • 7.8.1 Allnex Radiation Curable Formulation Corporation Information
  • 7.8.2 Allnex Radiation Curable Formulation Product Portfolio
  • 7.8.3 Allnex Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.8.4 Allnex Main Business and Markets Served
  • 7.7.5 Allnex Recent Developments/Updates
• 7.9 Chongqing Changfeng Chemical
  • 7.9.1 Chongqing Changfeng Chemical Radiation Curable Formulation Corporation Information
  • 7.9.2 Chongqing Changfeng Chemical Radiation Curable Formulation Product Portfolio
  • 7.9.3 Chongqing Changfeng Chemical Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.9.4 Chongqing Changfeng Chemical Main Business and Markets Served
  • 7.9.5 Chongqing Changfeng Chemical Recent Developments/Updates
• 7.10 Eternal Materials
  • 7.10.1 Eternal Materials Radiation Curable Formulation Corporation Information
  • 7.10.2 Eternal Materials Radiation Curable Formulation Product Portfolio
  • 7.10.3 Eternal Materials Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.10.4 Eternal Materials Main Business and Markets Served
  • 7.10.5 Eternal Materials Recent Developments/Updates
• 7.11 Miwon Specialty Chemical
  • 7.11.1 Miwon Specialty Chemical Radiation Curable Formulation Corporation Information
  • 7.11.2 Miwon Specialty Chemical Radiation Curable Formulation Product Portfolio
  • 7.11.3 Miwon Specialty Chemical Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.11.4 Miwon Specialty Chemical Main Business and Markets Served
  • 7.11.5 Miwon Specialty Chemical Recent Developments/Updates
• 7.12 Jiangsu Sanmu Group
  • 7.12.1 Jiangsu Sanmu Group Radiation Curable Formulation Corporation Information
  • 7.12.2 Jiangsu Sanmu Group Radiation Curable Formulation Product Portfolio
  • 7.12.3 Jiangsu Sanmu Group Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.12.4 Jiangsu Sanmu Group Main Business and Markets Served
  • 7.12.5 Jiangsu Sanmu Group Recent Developments/Updates
• 7.13 PPG
  • 7.13.1 PPG Radiation Curable Formulation Corporation Information
  • 7.13.2 PPG Radiation Curable Formulation Product Portfolio
  • 7.13.3 PPG Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.13.4 PPG Main Business and Markets Served
  • 7.13.5 PPG Recent Developments/Updates
• 7.14 T&K TOKA
  • 7.14.1 T&K TOKA Radiation Curable Formulation Corporation Information
  • 7.14.2 T&K TOKA Radiation Curable Formulation Product Portfolio
  • 7.14.3 T&K TOKA Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.14.4 T&K TOKA Main Business and Markets Served
  • 7.14.5 T&K TOKA Recent Developments/Updates
• 7.15 Heygey
  • 7.15.1 Heygey Radiation Curable Formulation Corporation Information
  • 7.15.2 Heygey Radiation Curable Formulation Product Portfolio
  • 7.15.3 Heygey Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.15.4 Heygey Main Business and Markets Served
  • 7.15.5 Heygey Recent Developments/Updates
• 7.16 Suzhou Mingda
  • 7.16.1 Suzhou Mingda Radiation Curable Formulation Corporation Information
  • 7.16.2 Suzhou Mingda Radiation Curable Formulation Product Portfolio
  • 7.16.3 Suzhou Mingda Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.16.4 Suzhou Mingda Main Business and Markets Served
  • 7.16.5 Suzhou Mingda Recent Developments/Updates
• 7.17 Himonia
  • 7.17.1 Himonia Radiation Curable Formulation Corporation Information
  • 7.17.2 Himonia Radiation Curable Formulation Product Portfolio
  • 7.17.3 Himonia Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.17.4 Himonia Main Business and Markets Served
  • 7.17.5 Himonia Recent Developments/Updates
• 7.18 Tianjin Jiuri New
  • 7.18.1 Tianjin Jiuri New Radiation Curable Formulation Corporation Information
  • 7.18.2 Tianjin Jiuri New Radiation Curable Formulation Product Portfolio
  • 7.18.3 Tianjin Jiuri New Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.18.4 Tianjin Jiuri New Main Business and Markets Served
  • 7.18.5 Tianjin Jiuri New Recent Developments/Updates

8 Radiation Curable Formulation Manufacturing Cost Analysis

• 8.1 Radiation Curable Formulation Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Key Raw Materials Price Trend
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Radiation Curable Formulation
• 8.4 Radiation Curable Formulation Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
• 9.2 Radiation Curable Formulation Distributors List
• 9.3 Radiation Curable Formulation Customers

10 Market Dynamics

• 10.1 Radiation Curable Formulation Industry Trends
• 10.2 Radiation Curable Formulation Growth Drivers
• 10.3 Radiation Curable Formulation Market Challenges
• 10.4 Radiation Curable Formulation Market Restraints

11 Production and Supply Forecast

• 11.1 Global Forecasted Production of Radiation Curable Formulation by Region (2022-2027)
• 11.2 North America Radiation Curable Formulation Production, Revenue Forecast (2022-2027)
• 11.3 Europe Radiation Curable Formulation Production, Revenue Forecast (2022-2027)
• 11.4 China Radiation Curable Formulation Production, Revenue Forecast (2022-2027)
• 11.5 Japan Radiation Curable Formulation Production, Revenue Forecast (2022-2027)

12 Consumption and Demand Forecast

• 12.1 Global Forecasted Demand Analysis of Radiation Curable Formulation
• 12.2 North America Forecasted Consumption of Radiation Curable Formulation by Country
• 12.3 Europe Market Forecasted Consumption of Radiation Curable Formulation by Country
• 12.4 Asia Pacific Market Forecasted Consumption of Radiation Curable Formulation by Region
• 12.5 Latin America Forecasted Consumption of Radiation Curable Formulation by Country

13 Forecast by Type and by Application (2022-2027)

• 13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
  • 13.1.1 Global Forecasted Production of Radiation Curable Formulation by Type (2022-2027)
  • 13.1.2 Global Forecasted Revenue of Radiation Curable Formulation by Type (2022-2027)
  • 13.1.3 Global Forecasted Price of Radiation Curable Formulation by Type (2022-2027)
• 13.2 Global Forecasted Consumption of Radiation Curable Formulation by Application (2022-2027)

14 Research Finding and Conclusion

15 Methodology and Data Source

• 15.1 Methodology/Research Approach
  • 15.1.1 Research Programs/Design
  • 15.1.2 Market Size Estimation
  • 15.1.3 Market Breakdown and Data Triangulation
• 15.2 Data Source
  • 15.2.1 Secondary Sources
  • 15.2.2 Primary Sources
• 15.3 Author List